Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 12/14/2016
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / -||UN / UN|
Administered by: Other Purchased by: Other
Symptoms: Anaphylactic reaction, Disability, Mental disorder
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Other Medications: No other medications
Current Illness: Unknown
Diagnostic Lab Data:
CDC 'Split Type': WAES1607VNM006550
Write-up:This solicited information has been received from an unknown source via the Company regarding unspecified number of patients of unknown demographics enrolled in a study. The patients'' concurrent condition, medical history and concomitant medications were not reported. On an unknown date, the patients were vaccinated with GARDASIL. There was over-immunization (also reported as disorderly immunization) anaphylaxis and mental (details unspecified) with GARDASIL vaccine that led to permanent or temporary disability of these patients. The outcome of the events were unknown at the time of this report. The causality assessment of the events were not provided. This is one of several reports received from the same reporter. Additional information is not expected as the reporter did not wish to be contacted.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166